Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis. It also provides point-of-service, preferred provider organization, health maintenance organization, and indemnity benefit plans, as well as health savings accounts and consumer-directed health plans. In addition, this segment offers Medicare and Medicaid products and services, as well as other medical products, such as medical management and data analytics services, medical stop loss insurance, workers' compensation administrative services, and products that provide access to its provider networks in select geographies. The Group Insurance segment offers life insurance products, including group term life insurance, voluntary spouse and dependent term life insurance, group universal life insurance, and accidental death and dismemberment insurance; disability insurance products; and long-term care insurance products, which provide the benefits to cover the cost of care in private home settings, adult day care, assisted living, or nursing facilities. The Large Case Pensions segment manages various retirement products comprising pension and annuity products primarily for tax-qualified pension plans. The company provides its products and services to employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Aetna Inc. was founded in 1853 and is based in Hartford, Connecticut.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
SymbolNYSE:AET
CUSIP00817Y10
Phone860-273-0123
Debt
Debt-to-Equity Ratio0.44
Current Ratio0.74
Quick Ratio0.74
Price-To-Earnings
Trailing P/E Ratio20.08
Forward P/E Ratio17.57
P/E Growth1.67
Sales & Book Value
Annual Sales$60.54 billion
Price / Sales1.07
Cash Flow$12.6686 per share
Price / Cash15.63
Book Value$48.46 per share
Price / Book4.09
Profitability
EPS (Most Recent Fiscal Year)$9.86
Net Income$1.90 billion
Net Margins5.77%
Return on Equity20.66%
Return on Assets5.93%
Miscellaneous
Employees47,950
Outstanding Shares327,400,000
Market Cap$63.69 billion
Aetna (NYSE:AET) Frequently Asked Questions
What is Aetna's stock symbol?
Aetna trades on the New York Stock Exchange (NYSE) under the ticker symbol "AET."
How often does Aetna pay dividends? What is the dividend yield for Aetna?
Aetna declared a quarterly dividend on Friday, May 18th. Shareholders of record on Wednesday, July 25th will be paid a dividend of $0.50 per share on Wednesday, August 1st. This represents a $2.00 annualized dividend and a yield of 1.01%. The ex-dividend date of this dividend is Tuesday, July 24th. View Aetna's Dividend History.
How will Aetna's stock buyback program work?
Aetna declared that its Board of Directors has approved a stock buyback plan on Friday, April 7th 2017, which authorizes the company to repurchase $4,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 98% of its shares through open market purchases. Shares repurchase plans are often an indication that the company's management believes its stock is undervalued.
How were Aetna's earnings last quarter?
Aetna Inc (NYSE:AET) released its earnings results on Thursday, August, 2nd. The company reported $3.43 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $3.04 by $0.39. The company had revenue of $15.56 billion for the quarter, compared to the consensus estimate of $15.59 billion. Aetna had a net margin of 5.77% and a return on equity of 20.66%. Aetna's revenue for the quarter was up .2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $3.42 earnings per share. View Aetna's Earnings History.
When is Aetna's next earnings date?
What price target have analysts set for AET?
12 brokerages have issued twelve-month price objectives for Aetna's stock. Their forecasts range from $179.00 to $212.00. On average, they expect Aetna's share price to reach $201.75 in the next twelve months. This suggests a possible upside of 1.9% from the stock's current price. View Analyst Price Targets for Aetna.
What is the consensus analysts' recommendation for Aetna?
12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aetna in the last year. There are currently 6 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Aetna.
What are Wall Street analysts saying about Aetna stock?
Here are some recent quotes from research analysts about Aetna stock:
- 1. According to Zacks Investment Research, "Aetna’s second-quarter 2018 earnings of $3.43 per share beat the Zacks Consensus Estimate by 11.7%. The company had reported earnings of $3.42 in the year-ago quarter. The earnings beat was mainly achieved on the back of a lower tax rate, which was partly offset by an increase in expenses. Aetna's shares have outperformed the industry in a year’s time. Also, the company has witnessed its estimates for the current year move upward over the last seven days. It gains largely from its growing Government business. The recent sale of its U.S. Group Life and Disability business will enable the company to focus on its core growth areas. The company is on track to be acquired by CVS Health. However, its revenues remain under pressure. Its membership has been declining and rising expenses continue to hurt." (8/6/2018)
- 2. Cantor Fitzgerald analysts commented, "Excluding the impact of the CVS merger, we continue to believe that 2018 is likely to be a transition year until the company’s investments and improved Medicare Star ratings pay dividends in 2019. The pending merger with CVS seems logical, especially as other vertical mergers have been announced in the health care services industry. We are now a few months from the expected close (before year-end 2018). Our standalone DCF-based target price of $202 assumes that AET can grow revenue at about 5% for the next few years with modest margin expansion." (8/2/2018)
Who are some of Aetna's key competitors?
Who are Aetna's key executives?
Aetna's management team includes the folowing people:
- Mr. Mark Thomas Bertolini, Chairman & CEO (Age 61)
- Ms. Karen Sue Lynch, Pres (Age 55)
- Mr. Shawn Michael Guertin, Exec. VP, CFO & Chief Enterprise Risk Officer (Age 54)
- Mr. Richard Michael Jelinek, Exec. VP and Head of Enterprise Strategy & Integration (Age 81)
- Ms. Margaret M. McCarthy, Exec. VP of Operations & Technology (Age 64)
Has Aetna been receiving favorable news coverage?
News articles about AET stock have been trending somewhat positive on Thursday, according to Accern Sentiment. Accern identifies negative and positive media coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Aetna earned a news impact score of 0.19 on Accern's scale. They also assigned press coverage about the company an impact score of 46.25 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near term. View Recent Headlines for Aetna.
Who are Aetna's major shareholders?
Aetna's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.12%), FMR LLC (2.36%), Dimensional Fund Advisors LP (1.12%), Janus Henderson Group PLC (1.01%), OppenheimerFunds Inc. (0.88%) and Bank of New York Mellon Corp (0.85%). Company insiders that own Aetna stock include Francis S Soistman Jr, Jeffrey E Garten, Karen S Lynch, Margaret M Mccarthy, Mark T Bertolini and Shawn M Guertin. View Institutional Ownership Trends for Aetna.
Which institutional investors are selling Aetna stock?
AET stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Arrowgrass Capital Partners US LP, Renaissance Technologies LLC, LSV Asset Management, PNC Financial Services Group Inc., Janus Henderson Group PLC, United Services Automobile Association and Canada Pension Plan Investment Board. Company insiders that have sold Aetna company stock in the last year include Karen S Lynch and Margaret M Mccarthy. View Insider Buying and Selling for Aetna.
Which institutional investors are buying Aetna stock?
AET stock was bought by a variety of institutional investors in the last quarter, including PointState Capital LP, Natixis, Robeco Institutional Asset Management B.V., Naya Capital Management UK Ltd., Cornerstone Wealth Management LLC, FMR LLC, Abrams Capital Management L.P. and Canyon Capital Advisors LLC. View Insider Buying and Selling for Aetna.
How do I buy shares of Aetna?
Shares of AET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Aetna's stock price today?
One share of AET stock can currently be purchased for approximately $198.01.
How big of a company is Aetna?
Aetna has a market capitalization of $63.69 billion and generates $60.54 billion in revenue each year. The company earns $1.90 billion in net income (profit) each year or $9.86 on an earnings per share basis. Aetna employs 47,950 workers across the globe.
How can I contact Aetna?
Aetna's mailing address is 151 FARMINGTON AVENUE, HARTFORD CT, 06156. The company can be reached via phone at 860-273-0123 or via email at [email protected]
MarketBeat Community Rating for Aetna (NYSE AET)
MarketBeat's community ratings are surveys of what our community members think about Aetna and other stocks. Vote "Outperform" if you believe AET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AET will underperform the S&P 500 over the long term. You may vote once every thirty days.
